Physician Practices See Strong Q1 2022, but Challenges Remain
Recent report shows physician revenues, compensation, and productivity rose in the first quarter of 2022, but so did subsidies and expenses.
Non-COVID Products Help Drive QIAGEN Q1 2022 Growth
Assay tech company shares that its Q1 2022 results were better than expected in spite of declines in COVID-19 product sales.
COVID-19 Revenues Bubble Hasn’t Burst, But It Is Leaking
What a difference a year makes. In Q4 2021, COVID-19 testing demand was cresting and lab companies with COVID-19 products were posting record—and ultimately unsustainable—revenue growth. Compared to this baseline, 15 of the 31 companies that had reported their...
Q4 Diagnostics Revenues Remain Strong Despite Fall in COVID-19 Testing
...
Already a member? Log in here
Q3 Diagnostics Revenues Remain Strong Despite Fall in COVID-19 Testing
...
Already a member? Log in here